Monoclonal Antibody Shows Protection Against Malaria
But is intravenous administration going to get in the way?
Stay updated with breaking news from Robert Seder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
But is intravenous administration going to get in the way?
One dose of a monoclonal antibody safely protected healthy adults from malaria infection during the 6-month malaria season in Mali, according to data published in The New England Journal of Medicine and presented at a medical conference.
The version of a virus to which we're first exposed can dictate how we respond to later variants and, maybe, how well vaccines work.
The monoclonal antibody L9LS showed excellent efficacy in preventing malaria in a small, proof-of-concept trial.
New York, Aug 5 (IANS) Single-dose of a new monoclonal antibody (mAb) has shown to be safe and highly protective in adults exposed to the malaria parasite,